Under the new structure, due to come into effect next ... including headwinds for $7 billion-a-year insulin product Lantus (insulin glargine) that accounted for nearly 20 per cent of the ...

Minnesota Attorney General Keith Ellison on Monday announced a settlement in a lawsuit against insulin manufacturer Novo Nordisk. Minnesota residents will now be able to get Novo Nordisk insulin ...

We are aware of reports regarding supply issues of insulin in the UK. Some of these reports are of insulins that are being discontinued and some are where there is a temporary shortage. Here’s the ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

2008 -Mumbai: Aventis Pharma has launched insulin drug Lantus in a prefilled disposable pen called Solostar. 2010 - Aventis Pharma Ltd has informed about the following changes which have taken ...